Medication Interactions with Sertraline (Zoloft)
Sertraline has significant interactions with multiple medications, most importantly with MAOIs which can cause potentially life-threatening serotonin syndrome, and should never be combined. 1
Major Interactions to Avoid
Absolutely Contraindicated
Monoamine Oxidase Inhibitors (MAOIs) 2, 1
- Examples: phenelzine, isocarboxazid, moclobemide, isoniazid, linezolid
- Risk: Life-threatening serotonin syndrome
- Requires 14-day washout period between stopping MAOIs and starting sertraline (and vice versa)
Pimozide (Orap) 1
- Risk: QT prolongation, potentially fatal arrhythmias
- Even low doses (2mg) of pimozide showed 40% increase in pimozide levels with sertraline
High-Risk Interactions
- SSRIs, SNRIs, tricyclic antidepressants
- Triptans (migraine medications)
- Tramadol, meperidine, methadone, fentanyl (opioids)
- St. John's Wort, L-tryptophan
- Risk: Serotonin syndrome with symptoms ranging from mild (confusion, agitation) to severe (hyperthermia, seizures, death)
Drugs Metabolized by CYP2D6 1
- Antiarrhythmics (propafenone, flecainide)
- Antipsychotics
- Tricyclic antidepressants
- Risk: Increased blood levels of these medications, potential toxicity
Anticoagulants/Antiplatelets 2, 1
- Warfarin, NSAIDs, aspirin
- Risk: Increased bleeding risk (8% increase in prothrombin time)
- Requires close monitoring of INR/prothrombin time
Moderate Interactions
Drugs Highly Bound to Plasma Proteins 1
- Warfarin, digitoxin
- Risk: Displacement from protein binding sites, altered drug levels
CNS Depressants
- Benzodiazepines, alcohol, sedatives
- Risk: Enhanced sedation, impaired psychomotor function
Drugs Affecting QT Interval 2
- Class Ia and III antiarrhythmics
- Some antipsychotics
- Risk: QT prolongation, arrhythmias
Cimetidine 1
- Increases sertraline levels by 50%
- Risk: Enhanced side effects of sertraline
Monitoring Recommendations
For High-Risk Combinations
- Monitor for signs of serotonin syndrome within 24-48 hours of combining medications 2
- Mental status changes: confusion, agitation, anxiety
- Neuromuscular symptoms: tremors, clonus, hyperreflexia, muscle rigidity
- Autonomic symptoms: hypertension, tachycardia, hyperthermia, diaphoresis
For Anticoagulants
- Check prothrombin time/INR within 1-2 weeks of starting sertraline 1
- Monitor for signs of bleeding: ecchymosis, epistaxis, petechiae
Special Populations
- Patients with seizure disorders: Use caution as SSRIs may lower seizure threshold 2
- Patients with bipolar disorder: Risk of triggering mania/hypomania 2
- Patients with liver impairment: Higher risk of drug interactions due to altered metabolism 1
Clinical Pearls
- Sertraline has fewer drug interactions compared to fluoxetine due to its shorter half-life
- When switching between sertraline and MAOIs, a 14-day washout period is mandatory 1
- Avoid abrupt discontinuation of sertraline to prevent discontinuation syndrome 2
- For patients requiring pain management, morphine, codeine, and oxycodone are safer options than tramadol or meperidine when combined with sertraline 3
By understanding these interactions and implementing appropriate monitoring, clinicians can minimize adverse events while effectively treating patients with sertraline.